Covid-19 vaccines Archives - DelveInsight

Covid-19 vaccines

Latest-medtech-news-updates-for-abbott-wren-smithnephew-hyalex
MedTech Wrap Up

Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High-Frequency Nerve Block SystemOn June 29, 2021, the US Food and Drug Administration (FDA) granted Neuros Me...


pharma-happenings-for-jnj-bayer-novo-prothena
Bayer’s CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk’s to get Prothena̵...

Bayer Scores FDA-Approval for its CKD Drug FinerenoneFollowing a priority review, the USFDA finally gave its thumbs-up to Bayer AG’s Kerendia (finerenone) for chronic kidney disease (CKD) asso...


Coronavirus-covid-19-vaccine-landscape
Charting out the COVID-19 Vaccine Landscape

The uncontrolled outbreaks of Covid-19 have brought unprecedented challenges to the world community. It has created an imbalance in mental, social, and economic well-being. Apart from this, it has...


recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos
InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio...

InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in ChinaInnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today...


Pfizer/BioNTech COVID-19 Vaccine; Biogen/Capsigen Deal
Abingworth & Alebund’s Finacial Closing; Pfizer/BioNTech COVID-19 Vaccine Expanded Use...

Abingworth Achieves Financial Close, Raises USD 582 MillionAbingworth, a London-based venture capital firm, has announced the closing of its new Clinical Co-Development Fund 2 (ACCD 2) worth U...


COVID-19-Vaccines-Hemophilia-B-uniQure-Gene-Therapy-J-J-Covid-Vaccine-Covaxin
Ocugen-Bharat Biotech’s Covaxin Against B.1.617 Corona Variant; uniQure Shares; J&J Covid V...

Ocugen-Bharat Biotech’s Covaxin Shows Efficacy Against B.1.617 VariantWith the COVID-19 cases exponentially increasing, there is a worrisome climate all over the world. Physicians, doctors, re...


Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche's Tecentriq Results in NSCLC
Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche’s Tecentriq R...

Promega Biotech Ibérica Gains Recognition for COVID-19 Response in SpainPromega Biotech Ibérica has been heralded as the business leader in Spain for its COVID-19 response. The company’s innov...


Aurinia's Lupkynis for Lupus; Toripalimab; Merck’s Covid-19 Vaccines fail
Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics...

Hot on the heels, Aurinia launches its drug in the Lupus market after GSKAurinia Pharmaceuticals has recently got the USFDA approval for its Lupkynis (voclosporin) in combination with a backgr...


Historic win for Pfizer's COVID-19 Vaccine; Alexion Buyout; and more
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech...

Gannex received US FDA fast track designation for its NASH drug, ASC42 an FXR AgonistGannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-al...


KaliVir, Astellas deal; AbCellera IPO; Bayer's CAR-T collabs; NASH therapy
KaliVir, Astellas licensing deal; AbCellera’s IPO; Bayer CAR-T Cell therapy collab with Ata...

KaliVir, Astellas Pharma forms a licensing deal for VET2-L2 oncolytic virusKaliVir Immunotherapeutics and Astellas Pharma entered into a worldwide exclusive licensing agreement for the develop...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.